SG/CALL/EDWARDS LIFESCIENCES/90/0.1/19.09.25 | Market Closed - Börse Stuttgart 02:57:56 03/07/2024 pm IST | ||
| 1.99 EUR | +2.05% |
|
| Current month | -7.87% | ||
| 1 month | +6.99% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 1.99 | +2.05% |
| 02/24/02 | 1.95 | -6.70% |
| 01/24/01 | 2.09 | -3.24% |
| 28/24/28 | 2.16 | +4.85% |
| 27/24/27 | 2.06 | -0.96% |
Delayed Quote Börse Stuttgart
Last update July 03, 2024 at 02:57 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SU95SC |
| ISIN | DE000SU95SC3 |
| Date issued | 01/03/2024 |
| Strike | 90 $ |
| Maturity | 19/09/2025 (443 Days) |
| Parity | 10 : 1 |
| Emission price | 2.16 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.72 € |
|---|---|
| Lowest since issue | 1.78 € |
| Spread | 0.09 € |
| Spread % | 4.41% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.13
USD
Spread / Average Target
+5.54%
- Stock Market
- Warrants
- Warrant
